Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

173 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Multicenter Phase 2 Trial to Evaluate the Efficacy of mFOLFOX6 + Cetuximab as Induction Chemotherapy to Achieve R0 Surgical Resection for Advanced Colorectal Liver Metastases (NEXTO Trial).
Mise Y, Hasegawa K, Saiura A, Oba M, Yamamoto J, Nomura Y, Takayama T, Hashiguchi Y, Shibasaki M, Sakamoto H, Yamagata S, Aoyanagi N, Kaneko H, Koyama H, Miyagawa S, Shinozaki E, Yoshida S, Nozawa H, Kokudo N. Mise Y, et al. Among authors: shinozaki e. Ann Surg Oncol. 2020 Oct;27(11):4188-4195. doi: 10.1245/s10434-020-08627-y. Epub 2020 Jun 8. Ann Surg Oncol. 2020. PMID: 32514802 Clinical Trial.
Chemotherapy for small-bowel Adenocarcinoma at a single institution.
Suenaga M, Mizunuma N, Chin K, Matsusaka S, Shinozaki E, Oya M, Ueno M, Yamaguchi T, Muto T, Konishi F, Hatake K. Suenaga M, et al. Among authors: shinozaki e. Surg Today. 2009;39(1):27-31. doi: 10.1007/s00595-008-3843-2. Epub 2009 Jan 8. Surg Today. 2009. PMID: 19132464
[Successful treatment with cetuximab combination chemotherapy in a case of FOLFOX-refractory rectal cancer with previously unresectable multiple liver metastases leading to complete resection].
Mitsuhashi K, Matsusaka S, Mizunuma N, Ichimura T, Ozaka M, Ogura M, Shinozaki E, Suenaga M, Chin K, Fujimoto Y, Saiura A, Yamamoto N, Hatake K. Mitsuhashi K, et al. Among authors: shinozaki e. Gan To Kagaku Ryoho. 2010 Nov;37(11):2203-7. Gan To Kagaku Ryoho. 2010. PMID: 21084828 Japanese.
Irinotecan monotherapy offers advantage over combination therapy with irinotecan plus cisplatin in second-line setting for treatment of advanced gastric cancer following failure of fluoropyrimidine-based regimens.
Oba M, Chin K, Kawazoe Y, Takagi K, Ogura M, Shinozaki E, Suenaga M, Matsusaka S, Mizunuma N, Hatake K. Oba M, et al. Among authors: shinozaki e. Oncol Lett. 2011 Mar;2(2):241-245. doi: 10.3892/ol.2011.242. Epub 2011 Jan 20. Oncol Lett. 2011. PMID: 22866071 Free PMC article.
173 results